[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:alcohol-associated-liver-disease":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":29,"states":30},"Alcohol-associated Liver Disease",3,2,[8,16,22],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05178069","LGG Supplementation in Patients With AUD and ALD",[12],"Phase 2","RECRUITING","2026-08-26T02:17:33.002248Z","2026-05-05T02:43:29.699360Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT07525258","Implementation Facilitation Pilot for Alcohol Use Disorder (AUD) in Alcohol-associated Liver Disease (ALD)",[],"2026-08-26T02:16:38.897933Z","2026-04-29T02:57:57.080937Z",{"nct_id":23,"title":24,"phases":25,"status":26,"updated_at":27,"content_modified":28},"NCT07678567","Pomegranate Dietary Supplements in AUD and ALD",[],"NOT_YET_RECRUITING","2026-08-26T02:15:45.413021Z","2026-07-05T03:45:20.442590Z",[],[]]